Anne Doering

Anne Doering

Directeur Financier/CFO chez VIVORYON THERAPEUTICS N.V.

Fortune : - $ au 31/05/2026

Consumer Services
Health Technology
Finance

Profil

Anne Marie Doering currently works at Vivoryon Therapeutics NV, as Chief Financial Officer & Executive Director from 2024.
Ms. Doering also formerly worked at BioNTech SE, as Director-Investor Relations, Merck KGaA, as Director-Group Strategy, Creathor Venture Management GmbH, as Investment Manager, and Franklin Templeton Investment Management Ltd. (Germany), as Portfolio Manager & Research Analyst from 2010 to 2019.
Ms. Doering received her graduate degree from the University of Pennsylvania, graduate degree from Joseph H Lauder Institute of Management & International, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/03/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Anne Doering

SociétésPosteDébut
VIVORYON THERAPEUTICS N.V. Directeur Financier/CFO 01/03/2024

Anciens postes connus de Anne Doering

SociétésPosteFin
Analyst-Equity 01/01/2019
Private Equity Investor 01/11/2010
MERCK KGAA Corporate Officer/Principal -
BIONTECH SE Investor Relations Contact -
Voir l'expérience en détail de Anne Doering

Formation de Anne Doering

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

5

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Consumer Services

Finance

Commercial Services

Health Technology

Finance

Consumer Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Anne Doering
🔇